Urgent call for action: Avoiding spread and re-urbanisation of yellow fever in Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 113, Issue 1, 2018, Pages 1-2

  Possas, Cristina ^a   Martins, Reinaldo Menezes ^a   de Oliveira, Ricardo Lourenço ^a   Homma, Akira ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

YELLOW FEVER VACCINE;

AEDES; ANIMAL; BRAZIL; EPIDEMIC; HUMAN; MOSQUITO CONTROL; PROCEDURES; PUBLIC HEALTH; URBANIZATION; YELLOW FEVER;

AEDES; ANIMALS; BRAZIL; EPIDEMICS; HUMANS; MOSQUITO CONTROL; NATIONAL HEALTH PROGRAMS; URBANIZATION; YELLOW FEVER; YELLOW FEVER VACCINE;

EID: 85039869828     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/0074-02760170361     Document Type: Editorial

References (16)

1. Bonaldo MC, Gómez MM, dos Santos AAC, de Abreu FVS, Ferreira-de-Brito A, de Miranda RM, et al. Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms. Mem Inst Oswaldo Cruz. 2017; 112(6): 447-51.
2. Campi-Azevedo AC, Costa-Pereira C, Antonelli LR, Fonseca CT, Teixeira-Carvalho A, Villela-Rezende G, et al. Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2016; 12(2): 491-502.
3. Cardoso JC, Almeida MAB, Santos E, Fonseca DF, Sallum MAM, Noll CA, et al. Yellow fever virus isolation from Haemagogus leucocelaenus and Aedes serratus mosquitoes in epizootic areas, northwestern Rio Grande do Sul state, Brazil, 2008. Emerg Infect Dis. 2010; 16(12): 1918-24.
4. CGSYF - Collaborative Group for Studies on Yellow Fever Vaccines. Duration of post-vaccination immunity against yellow fever in adults. Vaccine. 2014; 32(39): 4977-84.
5. Couto-Lima D, Madec Y, Bersot MI, Campos SS, Motta MA, Santos FBD, et al. Potential risk of re-emergence of urban transmission of Yellow Fever virus in Brazil facilitated by competent Aedes populations. Sci Rep. 2017; 7(1): 4848.
6. Franco O. História da febre amarela no Brasil. Rio de Janeiro: Ministério da Saúde/Departamento Nacional de Endemias Rurais; 1969.
7. Jentes ES, Poumerol G, Gershman MD, Hill DR, Lemarchand J, Lewis RF, et al. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect Dis. 2011; 11(8): 622-32.
8. Martins RM, Maia MLS, Santos EWM, Cruz RLS, Santos PRG, Carvalho SMD, et al. Yellow Fever vaccine post-marketing surveillance in Brazil. Procedia Vaccinol. 2010; 2: 178-83.
9. Martins RM, Pavão ALB, Oliveira PMN, Santos PRG, Carvalho SMD, Mohrdieck R, et al. Adverse events following yellow fever immunization: report and analysis of 67 neurological cases in Brazil. Vaccine. 2014; 32(49): 6676-82.
10. Mir D, Delatorre E, Bonaldo M, Lourenço-de-Oliveira R, Vicente AC, Bello G. Phylodynamics of Yellow Fever virus in the Americas: new insights into the origin of the 2017 Brazilian outbreak. Sci Rep. 2017; 7(1): 7385.
11. MS - Ministério da Saúde. Manual de vigilância epidemiológica de eventos adversos pós-vacinação. 3ª ed. Brasília: Ministério da Saúde/SVS; 2014.
12. MS/SVS - Ministério da Saúde/Secretaria de Vigilância em Saúde. Centre for Emergency Operations in Public Health on Yellow Fever. Inform 43. Brasília: 2017. Available from: http://portalarquivos.saude.gov.br/images/pdf/2017/junho/02/COES-FEBRE-AMARELA---INFORME-43---Atualiza----o-em-31maio2017.pdf.
13. Souza RP, Foster PG, Sallum MA, Coimbra TL, Maeda AY, Silveira VR, et al. Detection of a new yellow fever virus lineage within the South American genotype I in Brazil. J Med Virol. 2010; 82(1): 175-85.
14. Staples JE, Monath TP, Gershman MD, Barrett ADT. Yellow fever vaccines. In: Plotkin SA, Orestein WA, Offit PA, Edwards KM, editors. Vaccines. 5th ed. Philadelphia: Saunders; 2008.
15. Vasconcelos PFC. Yellow fever in Brazil: thoughts and hypotheses on the emergence in previously free areas. Rev Saude Publica. 2010; 44(6): 5 pp.
16. WHO - World Health Organization. Yellow fever resurgence: impact of mass vaccination campaigns. Emergence, preparedness and response. Geneva: WHO; 2017. Available from: http://www.who.int/csr/disease/yellowfev/massvaccination/en/.